Search Results Search Sort by RelevanceMost Recent Podcast May 2010 Ethics Talk: Cosmetic Surgery - Is it Cheating? Our Society's Mixed Views about Cosmetic Surgery Virtual Mentor asked six "people on the street" in Chicago for their views about the personal and social effects of elective cosmetic surgery. State of the Art and Science Mar 2009 Type 2 Diabetes: Lifestyle Changes and Drug Treatment Natalie A. Brooks, PharmD The principal therapies for type 2 diabetes and the benefits and possible side effects associated with each. Virtual Mentor. 2009;11(3):237-241. doi: 10.1001/virtualmentor.2009.11.3.cprl1-0903. Case and Commentary May 2009 Competitiveness Can Undermine Team Goals, Commentary 2 Laurel C. Blakemore, MD Competitive behaviors can undermine a clerkship student’s residency goals and weaken team collaboration and communication. Virtual Mentor. 2009;11(5):370-372. doi: 10.1001/virtualmentor.2009.11.5.ccas3-0905. State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407 Case and Commentary Dec 2004 Confusion over Cholesterol Testing, Commentary 1 Kenneth W. Goodman, PhD Physicians must stay up-to-date on changes in clinical treatment guidelines. Virtual Mentor. 2004;6(12):536-538. doi: 10.1001/virtualmentor.2004.6.12.ccas2-0412. Case and Commentary Dec 2004 Confusion over Cholesterol Testing, Commentary 2 Eta S. Berner, EdD Physicians must stay up-to-date on changes in clinical treatment guidelines. Virtual Mentor. 2004;6(12):539-541. doi: 10.1001/virtualmentor.2004.6.12.ccas2-0412. Case and Commentary Aug 2004 Helping Surrogate Decision Makers in the Face of Uncertainty Robert W. Taylor, MD Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication. Virtual Mentor. 2004;6(8):342-344. doi: 10.1001/virtualmentor.2004.6.8.ccas2-0408. In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Pagination First page « First Previous page ‹ Previous … Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Current page 14 Page 15 Next page Next › Last page Last »
Podcast May 2010 Ethics Talk: Cosmetic Surgery - Is it Cheating? Our Society's Mixed Views about Cosmetic Surgery Virtual Mentor asked six "people on the street" in Chicago for their views about the personal and social effects of elective cosmetic surgery.
State of the Art and Science Mar 2009 Type 2 Diabetes: Lifestyle Changes and Drug Treatment Natalie A. Brooks, PharmD The principal therapies for type 2 diabetes and the benefits and possible side effects associated with each. Virtual Mentor. 2009;11(3):237-241. doi: 10.1001/virtualmentor.2009.11.3.cprl1-0903.
Case and Commentary May 2009 Competitiveness Can Undermine Team Goals, Commentary 2 Laurel C. Blakemore, MD Competitive behaviors can undermine a clerkship student’s residency goals and weaken team collaboration and communication. Virtual Mentor. 2009;11(5):370-372. doi: 10.1001/virtualmentor.2009.11.5.ccas3-0905.
State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407
Case and Commentary Dec 2004 Confusion over Cholesterol Testing, Commentary 1 Kenneth W. Goodman, PhD Physicians must stay up-to-date on changes in clinical treatment guidelines. Virtual Mentor. 2004;6(12):536-538. doi: 10.1001/virtualmentor.2004.6.12.ccas2-0412.
Case and Commentary Dec 2004 Confusion over Cholesterol Testing, Commentary 2 Eta S. Berner, EdD Physicians must stay up-to-date on changes in clinical treatment guidelines. Virtual Mentor. 2004;6(12):539-541. doi: 10.1001/virtualmentor.2004.6.12.ccas2-0412.
Case and Commentary Aug 2004 Helping Surrogate Decision Makers in the Face of Uncertainty Robert W. Taylor, MD Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication. Virtual Mentor. 2004;6(8):342-344. doi: 10.1001/virtualmentor.2004.6.8.ccas2-0408.
In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.